DOCS Stock Price, Doximity, Inc. Quote, Chart

Market Summary

USD23.88-0.49

Market Closed

-2.01%

DOCS Stock Price

View Fullscreen

DOCS RSI Chart

DOCS Valuation

Market Cap

4.5B

Price/Earnings (Trailing)

32.97

Price/Sales (Trailing)

9.69

EV/EBITDA

23.94

Price/Free Cashflow

27.23

DOCS Price/Sales (Trailing)

DOCS Profitability

Operating Margin

88.94%

EBT Margin

37.15%

Return on Equity

15.92%

Return on Assets

13.75%

Free Cashflow Yield

3.67%

DOCS Fundamentals

DOCS Revenue

Revenue (TTM)

468.3M

Rev. Growth (Yr)

17.37%

Rev. Growth (Qtr)

19.08%

DOCS Earnings

Earnings (TTM)

137.6M

Earnings Growth (Yr)

43.29%

Earnings Growth (Qtr)

56.71%

Breaking Down DOCS Revenue

Last 7 days

0.3%

Last 30 days

-5.6%

Last 90 days

-11.1%

Trailing 12 Months

-29.0%

How does DOCS drawdown profile look like?

DOCS Financial Health

Current Ratio

8.03

DOCS Investor Care

Buy Backs (1Y)

3.52%

Diluted EPS (TTM)

0.67

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	419.1M	436.9M	448.3M	468.3M
2022	343.5M	361.5M	384.4M	401.7M
2021	206.9M	243.2M	277.4M	316.6M
2020	116.4M	139.0M	161.6M	184.3M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Doximity, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	wampler kira scherer	acquired	-	-	2,500	-
Apr 01, 2024	wampler kira scherer	sold	-67,425	26.97	-2,500	-
Mar 01, 2024	wampler kira scherer	sold	-69,700	27.88	-2,500	-
Mar 01, 2024	wampler kira scherer	acquired	-	-	2,500	-
Feb 21, 2024	emergence capital partners ii lp	sold	-	-	-1,928,000	-
Feb 21, 2024	emergence capital partners ii lp	acquired	-	-	1,928,000	-
Feb 21, 2024	spain kevin	sold	-	-	-1,928,000	-
Feb 21, 2024	spain kevin	acquired	-	-	1,928,000	-
Feb 16, 2024	overpeck craig	sold	-45,030	30.02	-1,500	see remarks
Feb 15, 2024	bryson anna	acquired	-	-	104,091	chief financial officer

Which funds bought or sold DOCS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-22.33	-607,000	1,775,000	-%
May 07, 2024	Arizona State Retirement System	reduced	-5.93	-87,125	808,753	0.01%
May 07, 2024	OPPENHEIMER ASSET MANAGEMENT INC.	added	18.87	50,882	412,261	0.01%
May 07, 2024	Swiss National Bank	reduced	-4.22	-510,234	5,807,180	-%
May 07, 2024	O'Dell Group, LLC	sold off	-100	-7,010	-	-%
May 07, 2024	Qsemble Capital Management, LP	new	-	830,470	830,470	0.18%
May 07, 2024	Washington Trust Advisors, Inc.	reduced	-36.77	-4,167	6,419	-%
May 07, 2024	SEI INVESTMENTS CO	added	36.49	222,834	942,132	-%
May 07, 2024	Cornerstone Planning Group LLC	reduced	-63.2	-2,396	1,109	-%
May 07, 2024	ASSETMARK, INC	new	-	673	673	-%

Are Funds Buying or Selling DOCS?

Are funds buying DOCS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DOCS

No. of Funds

Unveiling Doximity, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	tangney jeffrey	31.5%	54,958,180	SC 13G/A
Feb 14, 2024	emergence capital partners ii lp	10.9%	14,462,728	SC 13G/A
Feb 13, 2024	vanguard group inc	9.23%	10,900,648	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 09, 2024	clearbridge investments, llc	5.0%	5,922,010	SC 13G/A
Feb 08, 2024	morgan stanley	5.7%	6,749,692	SC 13G/A
Jan 30, 2024	baillie gifford & co	5.33%	6,299,503	SC 13G
Jan 25, 2024	blackrock inc.	8.9%	10,540,334	SC 13G
Sep 08, 2023	morgan stanley	7.6%	9,556,526	SC 13G/A
Mar 08, 2023	blackrock inc.	4.5%	5,381,384	SC 13G/A

Recent SEC filings of Doximity, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 02, 2024	4	Insider Trading
Apr 01, 2024	144	Notice of Insider Sale Intent
Mar 04, 2024	4	Insider Trading
Mar 01, 2024	144	Notice of Insider Sale Intent
Feb 23, 2024	4	Insider Trading
Feb 23, 2024	4	Insider Trading
Feb 16, 2024	4	Insider Trading
Feb 16, 2024	4	Insider Trading
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 14, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Doximity, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	463.9B	371.6B	9.96%	1.73%	20.73	1.25	14.64%	11.24%
CI	98.7B	206.0B	-4.33%	31.01%	25.6	0.48	12.55%	-43.95%
HCA	81.0B	66.7B	-4.37%	13.20%	14.81	1.21	9.59%	-4.59%
CVS	68.9B	360.9B	-25.27%	-20.02%	9.41	0.19	9.07%	78.49%
CNC	40.5B	155.5B	4.29%	11.16%	14.8	0.26	6.34%	84.42%
DVA	11.9B	12.3B	3.05%	54.33%	14.61	0.97	5.77%	58.74%
UHS	11.7B	14.3B	-2.27%	18.37%	16.36	0.82	6.59%	6.24%
MID-CAP
CHE	8.8B	2.3B	-7.98%	4.98%	30.96	3.83	5.96%	18.29%
ACHC	6.3B	3.0B	-11.24%	-2.13%	-553.66	2.09	10.92%	-104.06%
AMN	2.3B	3.8B	3.83%	-33.34%	10.84	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.08%	8.52%	34.65	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.7B	1.1B	2.42%	25.02%	26.07	1.57	11.45%	30.74%
BKD	1.3B	3.0B	8.71%	84.46%	-7.02	0.44	6.74%	20.73%
BEAT	54.0M	-	-2.35%	-2.35%	-3.69	-	-	-12.94%
AMS	19.6M	21.3M	10.24%	15.77%	36.7	0.92	8.00%	-62.25%

Doximity, Inc. News

Latest updates

Doximity, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Revenue	19.1%	135	114	108	111	115	102	91.00	94.00	98.00	79.00	73.00	67.00	59.00	45.00	36.00	-
Cost Of Revenue	-4.5%	12.00	13.00	13.00	14.00	14.00	13.00	13.00	12.00	11.00	9.00	8.00	8.00	8.00	7.00	8.00	-
Gross Profit	22.1%	123	101	95.00	97.00	102	89.00	78.00	82.00	87.00	70.00	65.00	59.00	51.00	38.00	29.00	-
Operating Expenses	-3.8%	65.00	67.00	66.00	64.00	63.00	57.00	56.00	54.00	51.00	45.00	40.00	36.00	33.00	27.00	26.00	-
S&GA Expenses	15.7%	35.00	30.00	34.00	33.00	33.00	29.00	28.00	26.00	26.00	21.00	19.00	18.00	17.00	14.00	13.00	-
R&D Expenses	-0.1%	20.00	20.00	22.00	22.00	21.00	19.00	19.00	17.00	16.00	15.00	13.00	13.00	11.00	10.00	10.00	-
EBITDA Margin	8.7%	0.39*	0.36*	0.36*	0.34*	0.33*	0.33*	0.33*	0.35*	0.36*	0.36*	0.35*	0.30*	0.13*	0.15*	0.18*	0.21*
Income Taxes	65.8%	15.00	9.00	6.00	6.00	7.00	7.00	0.00	-8.82	-19.84	-10.72	-1.40	1.00	5.00	0.00	0.00	-
Earnings Before Taxes	58.8%	63.00	40.00	35.00	37.00	41.00	33.00	22.00	28.00	36.00	25.00	25.00	23.00	23.00	10.00	2.00	-
EBT Margin	9.6%	0.37*	0.34*	0.33*	0.32*	0.31*	0.31*	0.31*	0.33*	0.34*	0.35*	0.33*	0.28*	0.13*	0.15*	0.17*	0.20*
Net Income	56.7%	48.00	31.00	28.00	31.00	33.00	26.00	22.00	37.00	56.00	36.00	26.00	21.00	17.00	10.00	1.00	-
Net Income Margin	7.0%	0.29*	0.27*	0.27*	0.27*	0.30*	0.37*	0.42*	0.45*	0.44*	0.36*	0.31*	0.24*	0.16*	0.18*	0.21*	0.26*
Free Cashflow	289.0%	50.00	13.00	57.00	47.00	48.00	39.00	44.00	46.00	27.00	19.00	33.00	37.00	24.00	13.00	9.00	-

Balance Sheet

(In Millions)

Balance Sheet												(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1
Assets	-2.4%	1,001	1,026	1,154	1,137	1,067	1,028	1,051	991	932	869	830	252
Current Assets	-2.5%	841	863	990	975	899	848	874	904	858	830	791	209
Cash Equivalents	13.5%	123	108	307	158	136	74.00	110	113	85.00	80.00	594	66.00
Net PPE	0.5%	12.00	12.00	12.00	11.00	12.00	12.00	11.00	8.00	8.00	8.00	8.00	8.00
Goodwill	0%	68.00	68.00	68.00	68.00	68.00	68.00	68.00	49.00	19.00	19.00	19.00	19.00
Liabilities	-11.7%	136	154	163	171	137	149	149	113	93.00	97.00	102	104
Current Liabilities	-15.0%	105	123	133	140	106	118	121	111	92.00	96.00	100	102
Shareholder's Equity	-0.8%	865	871	991	966	930	879	902	879	839	773	728	67.00
Retained Earnings	-28.6%	61.00	85.00	225	218	203	170	205	191	154	99.00	63.00	36.00
Additional Paid-In Capital	1.7%	808	795	778	762	746	731	715	703	688	674	666	30.00
Shares Outstanding	-1.2%	186	189	195	194	193	193	193	192	154	186	88.00	74.00

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Cashflow From Operations	288.1%	50,054	12,898	57,200	46,639	48,697	39,514	44,752	46,964	27,284	19,152	33,175	37,551	23,961	12,701	8,760	-
Share Based Compensation	-12.5%	11,771	13,447	14,001	12,991	13,984	11,353	9,506	9,809	9,834	6,672	5,127	2,870	2,220	1,179	983	-
Cashflow From Investing	180.1%	40,132	-50,102	117,326	-13,204	13,304	-18,523	-41,500	-23,626	-25,520	-534,005	-57,423	-42,869	-27,267	14,529	-14,810	-
Cashflow From Financing	53.1%	-75,500	-161,122	-25,824	-11,862	779	-57,409	-5,969	4,392	3,794	53.00	552,176	1,736	2,324	1,124	223	-
Buy Backs	-95.3%	8,000	170,363	21,755	15,282	21.00	61,168	8,874	-	-	-	2,698	1,652	370	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

DOCS Income Statement

2023-12-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 135,284	$ 115,262	$ 357,365	$ 308,086
Cost of revenue	12,190	13,526	38,102	39,813
Gross profit	123,094	101,736	319,263	268,273
Operating expenses:
Research and development	19,946	20,519	61,835	58,645
Sales and marketing	34,956	33,220	99,612	90,375
General and administrative	9,641	9,513	27,854	26,986
Restructuring	0	0	7,936	0
Total operating expenses	64,543	63,252	197,237	176,006
Income from operations	58,551	38,484	122,026	92,267
Other income, net	4,481	2,461	15,223	4,173
Income before income taxes	63,032	40,945	137,249	96,440
Provision for income taxes	15,076	7,477	30,285	14,290
Net income	$ 47,956	$ 33,468	$ 106,964	$ 82,150
Net income per share attributable to Class A and Class B common stockholders:
Basic (in dollars per share)	$ 0.26	$ 0.17	$ 0.56	$ 0.43
Diluted (in dollars per share)	$ 0.24	$ 0.16	$ 0.52	$ 0.38
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic (in shares)	186,309	192,805	191,302	192,963
Diluted (in shares)	200,463	212,065	207,265	213,656

DOCS Balance Sheet

2023-12-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 123,089	$ 158,027
Marketable securities	587,149	682,972
Accounts receivable, net of allowance for doubtful accounts of $1,714 and $887 at December 31, 2023 and March 31, 2023, respectively	97,584	107,047
Prepaid expenses and other current assets	27,191	22,289
Deferred contract costs, current	5,886	5,118
Total current assets	840,899	975,453
Property and equipment, net	11,839	11,279
Deferred income tax assets	37,204	34,907
Operating lease right-of-use assets	12,808	13,819
Intangible assets, net	28,379	31,836
Goodwill	67,940	67,940
Other assets	1,580	1,654
Total assets	1,000,649	1,136,888
Current liabilities:
Accounts payable	1,880	1,272
Accrued expenses and other current liabilities	34,079	31,245
Deferred revenue, current	66,694	105,238
Operating lease liabilities, current	2,109	1,752
Total current liabilities	104,762	139,507
Deferred revenue, non-current	166	198
Operating lease liabilities, non-current	12,947	13,885
Contingent earn-out consideration liability, non-current	10,787	15,942
Income taxes payable, non-current	6,532	99
Other liabilities, non-current	841	1,141
Total liabilities	136,035	170,772
Commitments and contingencies (Note 13)
Stockholders' Equity
Preferred stock, $0.001 par value; 100,000 shares authorized as of December 31, 2023 and March 31, 2023, respectively; zero shares issued and outstanding as of December 31, 2023 and March 31, 2023, respectively	0	0
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of December 31, 2023 and March 31, 2023, respectively; 186,175 and 193,941 shares issued and outstanding as of December 31, 2023 and March 31, 2023, respectively	186	194
Additional paid-in capital	808,078	762,150
Accumulated other comprehensive loss	(4,653)	(14,083)
Retained earnings	61,003	217,855
Total stockholders’ equity	864,614	966,116
Total liabilities and stockholders’ equity	$ 1,000,649	$ 1,136,888

About Doximity, Inc.

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

CEO	Mr. Jeffrey A. Tangney
WEBSITE	doximity.com
INDUSTRY	Healthcare Plans
EMPLOYEES	900

Doximity, Inc. Frequently Asked Questions

What is the ticker symbol for Doximity, Inc.? What does DOCS stand for in stocks?

DOCS is the stock ticker symbol of Doximity, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Doximity, Inc. (DOCS)?

As of Tue May 07 2024, market cap of Doximity, Inc. is 4.54 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DOCS stock?

You can check DOCS's fair value in chart for subscribers.

What is the fair value of DOCS stock?

You can check DOCS's fair value in chart for subscribers. The fair value of Doximity, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Doximity, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DOCS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Doximity, Inc. a good stock to buy?

The fair value guage provides a quick view whether DOCS is over valued or under valued. Whether Doximity, Inc. is cheap or expensive depends on the assumptions which impact Doximity, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DOCS.

What is Doximity, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, DOCS's PE ratio (Price to Earnings) is 32.97 and Price to Sales (PS) ratio is 9.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DOCS PE ratio will change depending on the future growth rate expectations of investors.